Study to Evaluate Safety Tolerability & Efficacy of Kyprolis (Carfilzomib) in Relapsed or Refractory Multiple Myeloma
Clinical trial NCT03934684 · COMPLETED
Trial details
- NCT number
- NCT03934684
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-16
- Primary completion
- 2023-03-23
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.